Stocktwits2d agobullish
SLS Stock Eyes Green Start To August After Nearly $6M In Fresh Institutional Buying: Retail Stays BearishOpus Capital held 385,604 shares worth about $5.69 million after increasing its position by 11.3%.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
542last 24h
2521last 7d
483● bullish (7d)
259● bearish (7d)
197publishers
Stocktwits7d agobullish
SLS Stock Heads For Worst Month In Over 2 Years — But Retail Bulls ‘Hold’ For AML Readout And Buyout HopesAn arbitrator recently dismissed Sellas’ claims against 3D Medicines and ordered about $1 million in legal-cost payments.
Stocktwits16d agobullish
SLS Stock Jumps Ahead Of CEO’s Fox Appearance: Retail Bets AML Readout Could Spark Big Pharma Bidding WarInvestors named Johnson & Johnson, Merck, Pfizer, AbbVie, Eli Lilly and Bristol Myers as possible bidders.
Stocktwits20d agobullish
SLS, IBRX Rise Overnight: Retail Bets On Big Pharma Buyouts As J&J Chases No. 1 Oncology SpotJ&J’s fast-growing Inlexzo bladder-cancer franchise could make IBRX either strategically attractive or a direct rival.
Stocktwits22d agobullish
SLS Stock Jumps Overnight After New Investor Disclosure – Retail Flags ‘Massive’ Options Bet Ahead Of AML DataCEO Angelos Stergiou said slower event accrual may signal a “highly effective active arm.”
Stocktwits23d agobullish
SLS Vs MLTX: Retail Traders Race To Pick Merck’s Next Biotech Buyout As Keytruda’s $31.7B Patent Cliff NearsSLS leads in stock momentum, while MLTX is cheaper and better-funded, with nearly $300 million in cash at the end of the first quarter.
Barchart29d agobullish
This Little-Known Stock Has Surged 550% in the Past YearSELLAS Life Sciences (SLS) has surged 550% in the past year, driven by technical momentum and speculative trading. SLS currently has no revenue, with all products in development or clinical trials, making the stock highly speculative. Technical indicators are overwhelmingly bullish, but high short interest highlights significant risk. Sentiment is...
Insider Monkey36d agobullish
Sellas Life (SLS) Climbs to Record High on Acquisition BuzzSellas Life Sciences Group Inc. (NASDAQ:SLS) is one of the 10 Stocks Investors Are Chasing Right Now. SELLAS Life Sciences extended its winning streak to an 8th straight session on Monday to soar to a new record high, as investors resumed buying positions after hinting at a potential takeover. In intra-day trading, the stock rocketed […]
Stocktwits36d agobullish
Why Did SLS, BB, OUST Stocks Surge To 52-Week Highs Today?Sellas Life Sciences, BlackBerry, and Ouster rallied to 52-week highs on Monday as investors rotated into the companies amid positive catalysts.
Stocktwits37d agobullish
Why Did SLS, MRNA, ABCL Stocks Surge To 52-Week Highs Last Week?Investor interest has focused on companies nearing key milestones, signing major partnerships, or improving their business outlook.
Stocktwits40d agobullish
SLS Short Interest Hits All-Time High: Sellas Bulls Smell A Short Squeeze As Executive Contract Changes Fuel Buyout ChatterSLS short interest climbed to nearly 33% of the float as of June 15, compared to 28.4% at the beginning of the year.
Stocktwits41d agobullish
SLS Stock Up 13% As Executive Severance Updates Reignite Buyout SpeculationThe company updated the severance agreements for three of its top executives, including the CEO.
Stocktwits68d agobullish
SLS Stock Rises Overnight: Traders Rally Behind Jim Cramer's 'Two Thumbs Up' Call Ahead Of Key AML ReadoutCEO Angelos Stergiou said the trial's extended duration suggests patients are living longer than originally projected and said the company remains "very bullish."
Stocktwits69d agobullish
SLS Stock Extends Rally Overnight: CEO Says ‘Bullish’ Leukemia Data Could Drive NCCN Recognition For GPSSellas believes GPS-treated AML patients could live longer than those receiving standard treatment, with a projected survival of about 12.6 months versus 8 months.
Stocktwits70d agobullish
SLS Stock Surges Toward Fifth Weekly Rise: CEO Touts GPS As Lifeline For Elderly Patients As Cancer Summit LoomsSellas will participate Wednesday in TD Cowen’s Oncology Innovation Summit, marking the final major conference appearance ahead of the Regal data release.
Stocktwits76d agobullish
Why Did ARM, SLS, EBAY Stocks Surge To 52-Week Highs?Arm Holdings surged more than 15%, while Sellas Life Sciences rallied by over 18% and eBay climbed up 4% at close.
Zacks132d agobullish
All You Need to Know About SELLAS Life Sciences Group, Inc. (SLS) Rating Upgrade to BuySELLAS Life Sciences Group, Inc. (SLS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.